Mason Street Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-35,872
Closed -$8.48M 1242
2020
Q4
$8.48M Sell
35,872
-711
-2% -$168K 0.14% 128
2020
Q3
$9.96M Sell
36,583
-432
-1% -$118K 0.19% 86
2020
Q2
$10.7M Buy
37,015
+326
+0.9% +$94.6K 0.22% 80
2020
Q1
$8.73M Hold
36,689
0.2% 90
2019
Q4
$8.03M Buy
36,689
+70
+0.2% +$15.3K 0.15% 115
2019
Q3
$6.2M Buy
36,619
+92
+0.3% +$15.6K 0.13% 147
2019
Q2
$6.7M Buy
36,527
+54
+0.1% +$9.9K 0.14% 130
2019
Q1
$6.71M Buy
36,473
+443
+1% +$81.5K 0.14% 134
2018
Q4
$5.97M Buy
36,030
+104
+0.3% +$17.2K 0.15% 127
2018
Q3
$6.92M Buy
35,926
+173
+0.5% +$33.3K 0.14% 122
2018
Q2
$6.08M Buy
35,753
+386
+1% +$65.6K 0.13% 137
2018
Q1
$5.76M Buy
35,367
+140
+0.4% +$22.8K 0.13% 141
2017
Q4
$5.28M Buy
35,227
+228
+0.7% +$34.2K 0.12% 153
2017
Q3
$5.32M Buy
34,999
+431
+1% +$65.5K 0.13% 145
2017
Q2
$4.46M Buy
34,568
+236
+0.7% +$30.4K 0.11% 176
2017
Q1
$3.75M Buy
34,332
+402
+1% +$44K 0.1% 216
2016
Q4
$2.5M Buy
33,930
+411
+1% +$30.3K 0.07% 352
2016
Q3
$2.92M Buy
33,519
+202
+0.6% +$17.6K 0.08% 275
2016
Q2
$2.87M Buy
33,317
+497
+2% +$42.8K 0.08% 269
2016
Q1
$2.61M Buy
32,820
+720
+2% +$57.2K 0.08% 291
2015
Q4
$4.04M Buy
32,100
+445
+1% +$56K 0.13% 157
2015
Q3
$3.3M Buy
31,655
+269
+0.9% +$28K 0.11% 185
2015
Q2
$3.88M Buy
31,386
+209
+0.7% +$25.8K 0.12% 164
2015
Q1
$3.68M Sell
31,177
-135,867
-81% -$16M 0.11% 189
2014
Q4
$19.8M Sell
167,044
-1,160
-0.7% -$138K 0.14% 190
2014
Q3
$18.9M Buy
168,204
+158
+0.1% +$17.7K 0.15% 169
2014
Q2
$15.9M Buy
168,046
+45,385
+37% +$4.3M 0.12% 204
2014
Q1
$8.68M Sell
122,661
-1,590
-1% -$112K 0.07% 342
2013
Q4
$9.23M Buy
124,251
+9,101
+8% +$676K 0.08% 311
2013
Q3
$8.73M Sell
115,150
-108,387
-48% -$8.22M 0.1% 252
2013
Q2
$17.9M Buy
+223,537
New +$17.9M 0.2% 135